Article
Heterochromatin fidelity is a therapeutic vulnerability in lymphoma and other human cancers
2025-02-05
Abstract excerpt
<h4>ABSTRACT</h4> Genes involved in the regulation of chromatin structure are frequently disrupted in cancer, contributing to an aberrant transcriptome and phenotypic plasticity. Yet, therapeutics targeting mutant forms of chromatin-modifying enzymes have yielded only modest clinical utility, underscoring the difficulty of targeting the epigenomic underpinnings of aberrant gene regulatory networks. Here, we sough...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c6c4217a-e7a9-5ad3-9281-80c93324aef4
- DOI
- 10.1101/2025.01.31.635709
